The drug, called Kisqali (ribociclib), is already approved for treating such patients -- based on earlier results showing it can delay the progression of their cancer.
from WebMD Health https://wb.md/2Wl7XWt
via IFTTT
The drug, called Kisqali (ribociclib), is already approved for treating such patients -- based on earlier results showing it can delay the progression of their cancer.
No comments:
Post a Comment